evaluating tarlatamab in recurrent small cell lung cancer treatment
Published 1 year ago • 4.8K plays • Length 3:22Download video MP4
Download video MP3
Similar videos
-
1:28
clinical trial: tarlatamab for small cell lung cancer (nct04885998)
-
18:16
dellphi-301 - fda approval of tarlatamab in patients w/ prev treated small cell lung cancer (sclc)
-
2:24
the dll3-targeting bite, tarlatamab, for the treatment of sclc
-
8:04
unlocking the secrets of small cell lung cancer: what you need to know now!
-
1:02
evaluating the role of systemic therapies in sclc
-
1:44
imdelltra™ (tarlatamab-dlle)- extensive stage small cell lung cancer
-
2:52
immunotherapy treatments for small cell lung cancer (sclc)
-
0:58
my lung cancer symptoms were being misdiagnosed multiple times!
-
3:50
charles’s journey with small cell lung cancer
-
3:13
clinical trial: bnt411 for small cell lung cancer (nct04101357)
-
16:40
small cell lung cancer (sclc) algorithm - drs. rohit & rahul gosain with dr. estelamari rodriguez
-
2:40
lindy’s experience with small cell lung cancer
-
5:13
clinical trial for early-stage non-small cell lung cancer following surgery
-
1:28
a need for continued research with immunotherapy in small cell lung cancer: 2022 esmo florida
-
16:04
lung cancer (part 1): 2021 comprehensive updates
-
0:59
5 treatment options for small cell lung cancer part 2 #sharecare #shorts
-
0:58
small cell lung cancer staging | lung cancer | kaizen oncology network
-
2:54
best results ever in the treatment of small cell lung cancer: immunotherapy in primary care
-
4:11
pamela’s small cell lung cancer story